- Home
- NEXN vs YDES Comparison
NEXN vs YDES Comparison
Compare NEXN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEXN | YDES |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | Israel | Taiwan |
| Employees | 909 | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.0M | 543.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NEXN | YDES |
|---|---|---|
| Price | $9.70 | $2.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.56 | N/A |
| AVG Volume (30 Days) | ★ 414.8K | 344.1K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.60 | $1.70 |
| 52 Week High | $11.16 | $25.00 |
Technical Indicators
Market Signals| Indicator | NEXN | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 56.70 | 42.29 |
| Support Level | $8.08 | $2.14 |
| Resistance Level | N/A | $3.05 |
| Average True Range (ATR) | 0.41 | 0.35 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 60.00 | 29.57 |
Price Performance
Historical ComparisonAbout NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from United States.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.